drugset / Trial / NCT02352922

Randomized Trial of Wound Infiltration With Extended-release Bupivacaine Before Laparoscopic or Robotic Hysterectomy

NCT02352922 ↗

Phase 4 Completed 64 enrolled AdventHealth
RandomizedParallel-groupDouble-blindTreatment

Summary

The investigators are studying ways to improve pain control after surgery. One way to decrease pain is to inject incisions with a numbing medicine (local anesthetic) while in the operating room. There is an FDA approved extended-release version of a commonly used local anesthetic (bupivacaine) that can last for 4 days instead of 6 hours. The investigators are studying whether using the extended-release medication (Exparel) will give better pain relief after laparoscopic and robotic-assisted hysterectomies.

Timeline

Start
2015-07
Primary completion
2016-01
Completion
2016-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 4 ml Other
Comparator Bupivacaine Other / unclassified 13.3 mg/ml Other

Indications